Krell Clinical Communications, Llc

Description

• Krell Clinical Communications creates readable, patient-friendly, visually enhanced informed consent documents and clinical trial materials for study sponsors and hospitals. Krell has focused on improving informed consent forms (ICFs) by correcting the problems of readability and comprehension.Krell Clinical Communications' proven solution for better informed consent is VECTER, visually enhanced informed consent documents written in plain language at or below 7th grade reading levels. VECTERs meet or exceed the recommendations and requirements of US and global regulatory authorities, local and central IRBs, as well as the International Conference on Harmonisation guidelines.Krell Clinical offers specialized communications expertise in drug development and clinical trials for CROs, pharmaceutical, biotechnology, and medical device companies. Krell has extensive knowledge of all phases of drug development, outsourcing, specialized clinical trial services and the various roles and sensitive relationships between sponsors, outsourced clinical trial teams, IRBs, investigators, and other stakeholders.Founded by Robert Krell to serve the specific needs of study sponsors, the company continues to produce award-winning solutions that exceed sponsor expectations in the areas of participant recruitment, investigator/participant education, and study branding.
• 

  Headquarters:112 Broad St , Flemington, New Jersey, United States

  More
• 

  Phone Number: +1 908-806-7477

• 

  Website: https://www.krellclinical.com

• 

  Employees:2

• 

  Revenue:$0 - 1M

• 

  Legal Name:Krell Clinical Communications, Llc

• Krell Clinical Communications, Llc's Social Media

  
• Is this data correct?

• |  NAICS Code: 809907  |

  Show More